Drug Profile
WIN 34B
Alternative Names: WIN-34BLatest Information Update: 04 Aug 2017
Price :
$50
*
At a glance
- Originator Hamsoa Pharmaceutical
- Class Analgesics; Anti-infectives; Anti-inflammatories; Herbal medicines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 04 Aug 2017 No recent reports of development identified - Phase-II for Osteoarthritis in South Korea (PO)